IGF2BP2 and head and neck squamous cell carcinoma: Through comprehensive bioinformatic analysis and experimental validation, we confirmed that miR-98-5p can target IGF2BP2 by direct binding to its 3′- UTR, which showed notable downregulation in HNSCC tissues after overexpressing miR-98-5p.